What is happening today in Washington is a travesty. And the only ones who can prevent it from going further are the people ...
Vertex's cloud growth momentum remains strong, with a 27% y/y increase in 4Q24. Read more to see why I upgrade VERX stock ...
Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...
Vertex Pharmaceuticals is flexing its innovation muscles beyond its cystic fibrosis stronghold, charging into new territories ...
After hours: March 27 at 6:34:52 PM EDT Loading Chart for VERX ...
To this end, and to gain more detailed insight into the localization of the relationship between the thickness of the PT and participants’ language experience, we ran three follow-up analyses, an ...